Literature DB >> 25789295

Highlights in pathogenesis of vitiligo.

Ghada F Mohammed1, Amal Ha Gomaa1, Mohammed Saleh Al-Dhubaibi1.   

Abstract

Vitiligo is a common pigmentary disorder. Many studies across decades and all over the world have attempted to illustrate the pathogenesis behind it; however, the pathogenesis of vitiligo remains elusive. This review article, we present the findings behind the most and updated theories behind this psychologically debilitating and disfiguring disease. The discussion begun with the role of genetic predisposition followed by neural theory first proposed in the 1950s. We highlight the autoimmune hypothesis, followed by the reactive oxygen species model, zinc-α2-glycoprotein deficiency hypothesis, viral theory, intrinsic theory and biochemical, molecular and cellular alterations accounting for loss of functioning melanocytes in vitiligo. Many theories were elaborated to clarify vitiligo pathogenesis. It is a multifactorial disease involving the interplay of several factors. Future research is needed to clarify the interaction of these factors for better understanding of vitiligo pathogenesis and subsequent successful treatment.

Entities:  

Keywords:  Etiopathogenesis; Non-segmental vitiligo; Pigmentary disorder; Segmental vitiligo; Vitiligo

Year:  2015        PMID: 25789295      PMCID: PMC4360494          DOI: 10.12998/wjcc.v3.i3.221

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  129 in total

1.  The centrosomal FOP protein is required for cell cycle progression and survival.

Authors:  Claire Acquaviva; Véronique Chevrier; Jean-Paul Chauvin; Gaëlle Fournier; Daniel Birnbaum; Olivier Rosnet
Journal:  Cell Cycle       Date:  2009-04-23       Impact factor: 4.534

2.  Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors.

Authors:  P R Gordon; C P Mansur; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1989-04       Impact factor: 8.551

3.  Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin.

Authors:  K U Schallreuter; M P Pittelkow
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Topically administered fluorouracil in vitiligo.

Authors:  T Tsuji; T Hamada
Journal:  Arch Dermatol       Date:  1983-09

5.  Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.

Authors:  Ai-Young Lee; Nan-Hyung Kim; Won-Ik Choi; Yun-Hee Youm
Journal:  J Invest Dermatol       Date:  2005-05       Impact factor: 8.551

6.  The developmentally-regulated Smoc2 gene is repressed by Aryl-hydrocarbon receptor (Ahr) signaling.

Authors:  Peijun Liu; Dorothy E Pazin; Rebeka R Merson; Kenneth H Albrecht; Cyrus Vaziri
Journal:  Gene       Date:  2008-12-24       Impact factor: 3.688

7.  Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo.

Authors:  Karin U Schallreuter; Souna M A Elwary; Nicholas C J Gibbons; Hartmut Rokos; John M Wood
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

8.  Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.

Authors:  Raymond E Boissy; Richard A Spritz
Journal:  Exp Dermatol       Date:  2009-03-06       Impact factor: 3.960

9.  Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.

Authors:  Silvia Moretti; Paolo Fabbri; Gianna Baroni; Samantha Berti; Daniele Bani; Emilio Berti; Romina Nassini; Torello Lotti; Daniela Massi
Journal:  Histol Histopathol       Date:  2009-07       Impact factor: 2.303

Review 10.  Vitiligo: new and emerging treatments.

Authors:  Torello Lotti; Alessia Gori; Fabio Zanieri; Roberta Colucci; Silvia Moretti
Journal:  Dermatol Ther       Date:  2008 Mar-Apr       Impact factor: 2.851

View more
  32 in total

1.  Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

Authors:  Lu-Mei Wang; Wan-Jiao Lu; Jing-Tao Yuan; Bi-Bing Zeng; Dan Li; Feng Zhang; Jun-Jie Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

Review 2.  Vitiligo following stem-cell transplant.

Authors:  Alessio Totani; Hossam Amin; Stephen Bacchi; Ian Lewis
Journal:  Bone Marrow Transplant       Date:  2019-07-29       Impact factor: 5.483

Review 3.  A Literature Review Investigating the Use of Topical Janus Kinase Inhibitors for the Treatment of Vitiligo.

Authors:  Christopher White; Richard Miller
Journal:  J Clin Aesthet Dermatol       Date:  2022-04

4.  Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.

Authors:  Pietro Sollena; Vasiliki Nikolaou; Nikolaos Soupos; Elias Kotteas; Dimitra Voudouri; Alexandros J Stratigos; Davide Fattore; Maria Carmela Annunziata; Armando Orlandi; Lucia Di Nardo; Zoe Apalla; Florian Deilhes; Maria Concetta Romano; Gabriella Fabbrocini; Vincent Sibaud; Ketty Peris
Journal:  Breast Cancer Res Treat       Date:  2020-09-10       Impact factor: 4.872

5.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

6.  Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.

Authors:  Doaa Salah Hegab; Mohamed Attia Saad Attia
Journal:  Dermatol Res Pract       Date:  2015-12-15

7.  Fibromyalgia Syndrome and Vitiligo: A Novel Association.

Authors:  Oula S Khudhair; Faiq I Gorial; Ammar F Hameed
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

8.  The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis.

Authors:  Yujie Dong; Qi Yang; Baofeng Guo; Jiajing Zhu; Xiaojie Sun
Journal:  Arch Dermatol Res       Date:  2020-08-12       Impact factor: 3.017

Review 9.  Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies.

Authors:  Ana Cláudia Guimarães Abreu; Gabriela Guy Duarte; Juliana Yasmin Pains Miranda; Daniel Gontijo Ramos; Camila Gontijo Ramos; Mariana Gontijo Ramos
Journal:  Autoimmune Dis       Date:  2015-09-17

Review 10.  Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents.

Authors:  Aleksandra Krzewska; Iwona Ben-Skowronek
Journal:  Biomed Res Int       Date:  2016-07-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.